The patients are part of Cabaletta’s RESET program across inflammatory muscle condition myositis, systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). Last month, the biotech shared ...

as well as trials in cutaneous lupus erythematosus and myositis. A sharp rise in measles cases in 2024 in Europe has led to widespread calls for a concerted effort to ramp up vaccination rates.

DESTIN, Fla. — Positive results for chimeric antigen receptor T-cell therapy in systemic sclerosis and myositis have added fuel to the fire of recent landmark data in lupus, said a speaker at ...

Artiva Biotherapeutics’ CEO Fred Aslan, MD, identifies data points the company is prioritizing to demonstrate that results from certain trials will translate to similar efficacy across a range of ...

With patients across the ongoing myositis, lupus and systemic sclerosis trials achieving DORIS remission in SLE, complete renal response in LN, and major TIS improvement in dermatomyositis ...